+86-13524779951 sales@xmobio.com
Products
  BIOACTIVE COMPOUND
  Anti-tumor series
  Antithrombotic series
  Anti-HCV series
  Rheumatism series
  Anti-diabetic series
  Nervous system series
  Others
  intermediate
  Featured products
  Others

This product is in stock,please ask for price.
If you have any question, please send the email to sales@xmobio.com for the availability.We will reply to you as soon as possible.
Shipment: Products are shipped via FedEx Express.
Products
Description
LY3200882 is a small molecule that has been shown in vitro to block TGFβ signaling, is being investigated in a phase I clinical trial. 
Chemical Structure
 
Chemical Name
2-(4-{4-[1-Cyclopropyl-3-(tetrahydro-pyran-4-yl)-1H-pyrazol-4-yloxy]-pyridin-2-ylamino}-pyridin-2-yl)-propan-2-ol 
Theoretical Analysis
XingMo Cat#:XM710 
Product Name:LY3200882 
Synonyms:LY3200882 , LY3200882 
CAS#:1898283-02-7 
Chemical Formula:C24H29N5O3 
Exact Mass:435.23 
Molecular Weight:435.52 
Purity:>98% 
Technical Data

Appearance: solid powder         

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years)

Solubility: Soluble in DMSO, not in water

Shelf Life:

>2 years if stored properly.

Drug Formulation:

This drug may be formulated in DMSO

Stock Solution Storage:

0 - 4 ℃ for short term (days to weeks), or -20 ℃ for long term (months).

 



WARNING: This product is for research use only, not for human or veterinary use

Tel: +8613524779951  QQ: 点击这里给我发消息
Email: sales@xmobio.com   Web: www.xmobio.com  沪ICP备17047952号-1
Copyright 2017 Shanghai xingMo Biotechnology Co., Ltd. All rights reserved. Supported by www.hxchem.net